Role of IL12 family in regulation of antitumor immune response

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The efficacy of immune therapy is partially dependent upon the tumor microenvironment. This microenvironment could either promote or demote tumor growth. Cytokines, which are secreted either by tumor, immune, or stromal cells, are key players that govern the outcome of this microenvironment. One such cytokine family is interleukin (IL)12 and the members of this family include IL12, IL27, IL23, and IL35. In this review, the expression and function of these family members and the cognate receptors in tumor microenvironment and other tissues are summarized and discussed. Our review indicates that, although these heterodimeric cytokines share subunits p35, p40, p19, EBI3, and p28 among these family members, each of them have distinct function. The same gene may also play different function when the expression is localized in different tissues.

Original languageEnglish (US)
Title of host publicationTargeted Cancer Immune Therapy
PublisherSpringer New York
Pages3-18
Number of pages16
ISBN (Print)9781441901699
DOIs
StatePublished - 2009
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Role of IL12 family in regulation of antitumor immune response'. Together they form a unique fingerprint.

Cite this